Algert Global LLC Applied Genetic Technologies Corp Transaction History

Algert Global LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 18, 2020	SELL	$2.69 - $4.92 $39,650 - $72,520	-14,740 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$2.59 - $4.16 $38,176 - $61,318	14,740 New	14,740 $61,000
Q1 2018 May 03, 2018	SELL	$3.65 - $5.2 $284,645 - $405,522	-77,985 Closed	0 $0
Q4 2017 Feb 01, 2018	BUY	$3.4 - $4.15 $12,036 - $14,691	3,540 Added 4.76%	77,985 $281,000
Q3 2017 Nov 17, 2017	BUY	$3.55 - $5.25 $264,279 - $390,836	74,445	74,445 $294,000

Ticker AGTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,632,200
Description
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.